White House nears deal to lower costs for popular weight loss drugs

NBC NewsWednesday, November 5, 2025 at 12:28:08 AM
PositiveHealth
White House nears deal to lower costs for popular weight loss drugs

The White House is reportedly close to finalizing a deal aimed at significantly lowering the costs of popular weight loss drugs, specifically Wegovy and Zepbound. According to NBC News, the agreement could reduce the price of these medications to as low as $149 per month for the lowest doses. This development is expected to be announced soon, reflecting ongoing efforts to make these treatments more affordable. The deal targets the cost structure of these drugs, which have been widely used for weight management. While specific details of the agreement have not yet been disclosed, the anticipated price reduction represents a notable shift in drug pricing policy. This move aligns with broader initiatives to improve access to essential medications. The forthcoming announcement is likely to have implications for patients and healthcare providers seeking effective weight loss options.

— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
PHOTO ESSAY: Coal miners with black lung fight Trump administration rollback of safety protections
NegativeHealth
In West Virginia, coal miners suffering from black lung disease are standing up against the Trump administration's rollback of crucial safety protections. This fight is significant as it highlights the ongoing struggles of miners who have long battled for their rights and health in an industry fraught with danger. The legacy of these workers is not just about the coal they extract, but also about the protections they have fought hard to secure for themselves and future generations.
Eli Lilly CEO talks deal to cut medication prices with the Trump administration
PositiveHealth
Eli Lilly's CEO, David Ricks, recently discussed a new agreement with the Trump administration aimed at reducing the prices of their weight loss drug, Zepbound. This deal is significant as it reflects a growing trend towards making essential medications more affordable for consumers, potentially improving access to treatment for many individuals struggling with weight management.
Trump announces deal to lower cost of weight loss drug
PositiveHealth
President Trump has announced a significant deal aimed at lowering the costs of popular weight loss drugs, Wegovy and Zepbound, for Medicare recipients. This move is set to bring relief to many individuals struggling with weight management, as the new pricing will take effect in 2026. The collaboration with pharmaceutical executives highlights a proactive approach to healthcare affordability, which is crucial for millions of Americans looking for effective weight loss solutions.
Trump Announces Deal to Drop Obesity Drug Prices to as Little as $149 a Month
PositiveHealth
President Trump has made a significant announcement regarding the prices of popular obesity drugs, Wegovy and Zepbound, which will now be available for as low as $149 a month. This deal with pharmaceutical giants Eli Lilly and Novo Nordisk aims to make these medications more accessible for Medicare, Medicaid, and self-paying patients. This move is crucial as it addresses the rising obesity rates in America and provides a more affordable option for those seeking effective weight-loss solutions.
SNAP recipients go without food after benefits delay
NegativeHealth
SNAP recipients are facing a dire situation as delays in November payments leave many without food. A judge has intervened, ordering the Trump administration to ensure that benefits are distributed by Friday. This delay is critical because it affects the most vulnerable populations who rely on these benefits for their daily sustenance, highlighting the urgent need for timely assistance.
Judge orders Trump administration to deliver full SNAP benefits to states by Friday
PositiveHealth
A federal judge in Rhode Island has mandated that the Trump administration must deliver full SNAP benefits to states by Friday. This decision is significant as it ensures that states receive the necessary funds to support low-income families who rely on these benefits for food security, especially during challenging economic times.
Federal judge orders Trump administration to fully fund SNAP benefits in November
PositiveHealth
A federal judge in Rhode Island has ordered the Trump administration to ensure full funding for SNAP benefits in November, a crucial decision for many families relying on this support. This ruling highlights the ongoing legal battles over social welfare programs and their funding, emphasizing the importance of food assistance during challenging times.
Trump announces deal with drugmakers to lower cost of weight loss drugs
PositiveHealth
President Trump has made a significant announcement regarding the cost of weight loss drugs, revealing that major drugmakers Novo Nordisk and Eli Lilly have agreed to lower prices for their GLP-1 medications, Wegovy and Zepbound. This move is expected to make these effective treatments more accessible to those struggling with weight management, highlighting a proactive approach to healthcare affordability.